IDEXX Laboratories Inc. Stock Rallies 21.8%, Outperforms Peers
Dow Jones2026/11/02 21:33This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of IDEXX Laboratories Inc. sailed 21.8% to $671.64 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,983.98 and the S&P 500 Index falling 0.5% to 7,541.40.
IDEXX Laboratories Inc. closed 12.8% short of its 52-week high of $769.98, which the company achieved on November 26th.
The stock outperformed some of its peers, as Johnson & Johnson fell 1.0% to $270.56, Medtronic PLC rose 2.8% to $99.29, and Boston Scientific Corp. rose 5.57% to $44.32.
Trading volume totaled 1.9 million, compared to the 50-day average of 510,474.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
November 02, 2026 16:33 ET (21:33 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Net profit surges fivefold but masks decline in core business; crypto mining companies' shift to AI poses hidden risks
Marathon Holdings' Q3 net profit reached $632 million, up 413% year-on-year. However, its mining revenue declined by 35%. The company relied on selling 13,500 BTC to pay off debts and is now betting on AI infrastructure, increasing the risk of an imbalanced profit structure.
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Crypto prices
More
